Apogee Enterprises filings document a Minnesota operating company with Nasdaq-listed common stock and disclosure centered on architectural building products, coated materials, and segment-level operations. Recent Form 8-K filings furnish quarterly and annual financial results, including sales, earnings measures, segment performance, guidance, debt, leverage, and exhibits to earnings releases.
The filing record also documents governance and executive-compensation matters, including officer appointments and departures, segment-president leadership changes, restricted stock awards, offer-letter terms, and grants under the Apogee Enterprises, Inc. 2019 Stock Incentive Plan. Other material-event disclosures cover capital-structure matters, material agreements, Regulation FD releases, and board or compensation committee actions.
Apogee Enterprises, Inc. (Nasdaq: APOG) filed a Form 8-K reporting the voting results from its June 25, 2025 Annual Meeting of Shareholders.
Director elections (Item 1): Class III nominees Elizabeth M. Lilly and Mark A. Pompa were re-elected for three-year terms expiring in 2028. Lilly received 17,448,093 for votes (≈ 98.9% of votes cast) and Pompa received 16,601,947 for votes (≈ 94.0%). Broker non-votes totaled 1,079,473 for each nominee.
Say-on-pay (Item 2): Shareholders approved the advisory resolution on executive compensation with 16,234,504 votes for (≈ 92.1%), 1,392,456 against, and 33,864 abstain.
Auditor ratification (Item 3): Deloitte & Touche LLP was re-appointed as independent auditor for fiscal 2026 with 18,487,452 for votes (≈ 98.7%) versus 238,253 against.
No other matters were brought before the meeting, and no financial results or strategic transactions were disclosed. The filing is largely procedural, confirming continued board composition, shareholder support for pay practices, and auditor continuity.
Apogee Enterprises Director Christina M. Alvord received 2,954 deferred restricted stock units (RSUs) on June 25, 2025, as part of the company's 2019 Non-Employee Director Stock Plan. Following this transaction, Alvord beneficially owns 10,274 deferred RSUs.
Key transaction details:
- The RSUs will be settled in common stock following the director's Board termination or other specified events
- The RSUs convert to common stock on a 1-for-1 basis
- The total beneficial ownership includes additional units acquired through dividend equivalent reinvestment
- The transaction was executed at $0 cost to the director
This Form 4 filing was signed by Meghan M. Elliott as attorney-in-fact for Christina M. Alvord on June 27, 2025, demonstrating standard insider equity compensation practices for non-employee directors.